RxSight, Inc. (RXST): Price and Financial Metrics
RXST Price/Volume Stats
| Current price | $14.92 | 52-week high | $60.81 |
| Prev. close | $15.26 | 52-week low | $12.53 |
| Day low | $14.89 | Volume | 533,100 |
| Day high | $15.59 | Avg. volume | 868,725 |
| 50-day MA | $16.22 | Dividend yield | N/A |
| 200-day MA | $34.90 | Market Cap | 606.30M |
RXST Stock Price Chart Interactive Chart >
RxSight, Inc. (RXST) Company Bio
RxSight, Inc., a medical technology company, develops light adjustable lens (LAL) to improve uncorrected visual acuity that can be adjusted enhance uncorrected visual acuity after cataract surgery. It also offers RxSight light delivery device, an office-based light treatment device that delivers UV light in a programmed pattern to modify the LAL based on the visual correction needed to achieve desired vision after cataract surgery. RxSight, Inc. was formerly known as Calhoun Vision, Inc. and changed its name to RxSight, Inc. in February 2017. The company was incorporated in 1997 and is based in Aliso Viejo, California.
RXST Latest News Stream
| Event/Time | News Detail | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
RXST Price Returns
| 1-mo | 0.13% |
| 3-mo | -40.56% |
| 6-mo | -65.42% |
| 1-year | -74.59% |
| 3-year | -9.02% |
| 5-year | N/A |
| YTD | -56.60% |
| 2024 | -14.73% |
| 2023 | 218.23% |
| 2022 | 12.62% |
| 2021 | N/A |
| 2020 | N/A |